Fonton, PĂ©rince
Hassoun-Kheir, Nasreen
Harbarth, Stephan
Funding for this research was provided by:
Federal Commission for Scholarships for Foreign Students for the Swiss Government Excellence Scholarship (ESKAS No. 2022 .0465)
Innovative Medicines Initiative 2, Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance [PrIMAVeRa] (101034420)
University of Geneva
Article History
Received: 16 February 2024
Accepted: 27 June 2024
First Online: 2 July 2024
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.